Abstract
Introduction
Since 2005 the European Association for the Study of Diabetes (EASD) invests in the education of diabetologists and facilitates the application of patient care by organizing postgraduate courses in different countries. I attended at one of these courses that was held in Prague between 29 and 31 October 2015. The topic for discussion concerned diabetes complications and its management. In the next sections I will present a brief report and my impressions from this postgraduate course. 
Course structure and participants

Take home messages
Diabetes (and its complications) is a vast subject, but the course organisers managed to cover all important topics in the short period of three days. Although all the presentations succeeded in capturing my attention, I will further mention only the four of them which I appreciated most.
Insulin pump and CGM in treatment of diabetes mellitus -Hood Thabit
Doctor Hood Thabit held a lecture about the advantages of insulin pump (continuous subcutaneous insulin injection or CSII) and continuous glucose monitoring (CGM) use in type 1 diabetes. Beside mentioning the results from observational and randomized studies that demonstrated the benefit on glycated haemoglobin (Hb1Ac) and hypoglycemia risk reduction, he emphasized the fact that CSII is associated with lower cardiovascular mortality than treatment with multiple daily insulin injections according to Steineck et al [1] .
Disproving the main reason for restricting this therapy, he presented a cost analysis of insulin pump use in the UK [2], in which ICER (Incremental Cost-Effectiveness Ratio) was 25.648£ per QALY (Quality-Adjusted Life Year). This may seem a large sum, but NICE-UK (The National Institute for Health and Care Excellence) considers an ICER between 20.000 and 30.000£ as cost effective; he also put in balance the direct and indirect costs of hypoglycemia that are underestimated by current economic models, for example, parents missing work days because their child had hypoglycemia.
Going further in the future, he presented the results of his 12-week randomized control study [3] , in which he compared a closed-loop system with sensor-augmented pump therapy in 58 patients with type 1 diabetes. He showed that the closed-loop system improves glucose control, reduces hypoglycemia, and, in adults, results in a lower glycated haemoglobin level.
Diabetes and driving -Jan Brož
Doctor Jan Brož explained to us the importance of driving legislation in patients with diabetes that experience hypoglycemia. In 2012, in agreement with the European Union legislation, the Czech Republic adopted a law which restricted the rights of diabetic patients with recurrent hypoglycemia [4,5], meaning that for personal vehicles driving (Group 1), two severe hypoglycemic events within 12 months is ground to revoke a driving license or deny its issuance. Physicians must inform the authorities when they suspect patients of having such episodes that impair their ability to hold a driving license [6] . In our country the law is similar [7] , but its enforcement is equivocal.
In this situation, it is possible that not all patients will be honest about their symptoms, leading to incorrect treatments and fatal accidents. Doctor Brož studied this aspect in the Czech population. He demonstrated that 26.17% of potentially affected insulin-treated diabetic patients would definitely not report (or would likely not report) severe hypoglycemia events during consultations under the present legislation, and 25.86% of the patients were undecided [6] . In addition to the standard education for diabetic patients that should include the risks of driving with hypoglycemia and information about driving license revocation or suspension, physicians are advised to include warnings regarding the risk of hypoglycemic event concealment [6] . Doctor Brož published a patient brochure in order to better educate diabetic patients [8] .
Current standards for managing diabetes in pregnancy -Elisabeth Mathiesen
Another interesting presentation was that of doctor Mathiesen. She began by presenting the changes in the insulin requirement in diabetic women during pregnancy. She synthesized all the current information about therapy in gestational diabetes comparing evidences for glibenclamide, metformin and insulin use [9] .
Together with her collaborators, she developed a free smartphone application named <Pregnant with Diabetes> intended for pregnant women with type 1 diabetes and type 2 diabetes, women that develop gestational diabetes, and also, diabetic women who wish to become pregnant. It offers information about what is diabetes, planning, possible complications, level of blood sugar, weight gain, diet, physical activity, insulin dose, scans, delivery and what happens after the birth (more information at: http://heyworld.dk/#/pregnant-with-diabetes/). This is a useful tool to educate pregnant women with diabetes and influence them to have a proactive attitude.
Diabetic foot -Edward Jude
Doctor Jude shared his experience regarding the diabetic foot syndrome and highlighted its most important features. In this lecture, but also in the workshop that followed, he focused on the factors that are associated with underlying osteomyelitis or can predict lower-extremity amputation. Independent risk factors for amputation are: peri-wound edema, foul smell, (non)purulent exudate, deep ulcer, positive probe-to-bone test, pretibial edema, fever, and elevated C-reactive protein [10] . He emphasized on two steps during patient assessment for osteomyelitis: probing ulcer (palpable bone with a probe) which has a sensitivity of 66%, specificity of 85% and positive predictive value of 89% [11] , and radiologic findings.
Another discussion was about diabetic Charcot foot. He asked about the management of this complication in our countries and we compared different approaches. Doctor Jude mentioned that the cornerstone of treatment is effective foot offloading [12] . Also, he specified one of his studies in which bisphosphonate treatment reduced bone turnover, symptoms and disease activity in diabetic patients with active Charcot neuroarthropathy [13] .
Conclusion
I consider that this experience helped me improve my practice skills. I had the opportunity to interact with doctors from other European countries and exchange our experience in the field of diabetes. I hope Romania will organize again such a constructive EASD postgraduate course, the last time being more than 10 years ago.
